Why hypoglycemia-induced glucagon secretion becomes impaired in diabetes

Findings indicate that excessive somatostatin inhibits glucagon secretion in type 1 diabetes, offering a novel target for hypoglycemia management strategies.

Meitheal partners with Chinese company for US licencing of insulin biosimilars – Pharmaceutical Technology

The availability of biosimilars can help reduce the cost of insulin therapies. Image Credit: Daniel Beckemeier / Shutterstock. Meitheal Pharmaceuticals has signed an exclusive licensing

September 21, 2023

Corbin Carroll homers twice off Austin Gomber as Rockies lose series finale 9-4 to Diamondbacks – The Cannabist

Before the Rockies’ relievers could even settle into their seats beyond the right-field wall, Corbin Carroll jolted them awake. Carroll’s 438-foot blast on Austin Gomber’s

September 19, 2024

Pharmalittle: PBMs are targeted in yet another congressional bill; access to new Alzheimer’s drug may not happen quickly

Rise and shine, another busy day is on the way. However, this is also shaping up as a beautiful day as well, given the clear

June 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.